The US Drug Watchdog says, "If you, a friend, or a loved one was using birth control pills called Yaz, Yasmin, or their generic version Ocella, and then developed a life threatening severe medical side effect such a pulmonary embolism, a heart attack, a stroke, or other severe medical conditions please contact The Johnson Law Group immediately at 1-800-996-9900. http://www.johnsonlawgroup.com/ (PRWEB) January 10, 2013 Possible Side Effects Yaz/Yasmin Birth Control Pills The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. We are attempting to change this very sad fact with aggressive initiatives focused on increasing public awareness, and hopefully suggesting possible help for victims." http://USDrugWatchdog.Com MDL No. 2100 (3:09-md-02100-DRH-PMF) M Thomas Martin Americas Watchdog 866-714-6466 Email Information Originally posted here: US Drug Watchdog Now Urges Users of Yaz or Yasmin Birth Control Pills Who Suffered A Life Threatening Medical Problem ... … Continue reading →

Orlando, FL (PRWEB) January 10, 2013 The prescription resource center DrugRisk.com has added information to its comprehensive database for women using the vaginal ring contraceptive NuvaRing which shows the number of claims filed over blood clot injuries has increased. The mission of DrugRisk is to improve patient safety through education, including the latest drug warnings, recalls, studies and litigation news. In many cases visitors want litigation information to know if others are experiencing similar problems and whether they have any options, explains DrugRisk representative Ryan Mayer. DrugRisk previously added warnings from experts that vaginal rings like NuvaRing may be linked to higher blood clot risks than traditional birth control pills. The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots. Now, the resource center has learned that the number of NuvaRing lawsuits filed over blood clots has risen by nearly 5% to 1076 from the last report, according to … Continue reading →

New York, NY (PRWEB) January 10, 2013 The prescription drug resource center DrugRisk.com is alerting patients who have taken the birth control drugs Yaz or Yasmin of the adition of new information to the site showing Switzerlands largest health insurer has joined in a lawsuit over allegations that Yasmin caused blood clots and pulmonary embolism. The mission of DrugRisk is to improve patient safety through education, including the latest medication warnings, recalls, studies and litigation news. Many visitors dont yet know the extent of health warnings and litigation surrounding the birth control drugs Yaz and Yasmin, explains DrugRisk representative Ryan Mayer. DrugRisk previously advised that thousands of Yaz lawsuits over blood clots filed in the U.S. have been consolidated to a special federal Multi-District Litigation court in Illinois. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois). The resource center reported on Bayers most recent financial statements, which show the company has spent nearly $750 million so far to settle approximately 3,500 of these claims, at an average of or around $214,000 per case.* Bayer confirmed they are only settling claims involving blood clot injuries, such … Continue reading →

NEW YORK (Reuters Health) - Doctors relying on studies published in top journals for guidance about how to treat women with breast cancer may not be getting the most accurate information, according to a new analysis. "Investigators want to go overboard to make their studies look positive," said Dr. Ian Tannock, the senior author of the new study in the Annals of Oncology. In two-thirds of the 164 studies Tannock and his colleagues scrutinized, that meant not listing toxicities - in other words, serious side effects, whether of chemotherapy, radiation or surgery - in the paper's abstract. Such abstracts summarize the findings, and run a few hundred words. That's important, said Tannock, of Princess Margaret Hospital in Toronto, because "most of us are so damn busy, we only read the abstract and skim the tables and figures." In fact, a fifth of studies didn't include toxicities in results tables, and about a third failed to mention them in either the abstract or the discussion section. Most surprising, said Tannock, was that in a third of studies, if the treatment didn't work as well as one might hope, researchers moved the goalposts, reporting results that weren't what the study was originally … Continue reading →

The DrugRisk Resource Center is the Webs largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Dallas, TX (PRWEB) January 10, 2013 DrugRisks goal is to improve patient safety through education of the latest drug warnings, recalls, studies and litigation news. In some cases, litigation can provide a look into drug studies and safety risks that werent previously made public, explains DrugRisk representative Ryan Mayer. The resource center recently advised of a warning by Australias Pharmaceutical Benefits Advisory Committee (PBAC) that the government may no longer furnish Pradaxa due to concerns that it is being prescribed at doses and patient ages not tested in clinical trials.* In the United States, experts disagree about the safety of Pradaxa and its bleeding risks. The FDA recently updated Pradaxa warnings to say the drug carries the same risks as warfarin.** However, the New York Times also reported doctors concerns that Pradaxa led all medications for adverse reports and currently has no antidote for internal bleeding.*** Due to the number of patients filing a Pradaxa lawsuit over internal bleeding, the cases have been moved to a special federal court in Illinois, formally known as MDL No. 2385, IN … Continue reading →